LDK Solar Co. (NYSE: LDK) American Depository Shares are jumping nearly 20% to $40.01, up from a close of $33.58, after the solar wafer manufacturer reported second-quarter results after the close.
LDK experienced some 200% sequential growth in net earnings to $149.5 million, or $1.29 per ADS. Even excluding the change in fair value of prepaid forward contracts, the company earned 82 cents a share, according to Reuters Estimates. That beat -- more like trounced -- analyst estimates of 40-42 cents a share. Revenues for the quarter were $441.7 million, up 345.9% year-over-year from $99.1 million, beating consensus of around $282 million.
The China-based multicrystalline solar wafer, solar cells and solar modules manufacturer said additional manufacturing capacity, which exceeded its own expectations, allowed the company to sell more solar wafers.
LDK didn't just beat estimates, it also raised guidance. It sees third-quarter revenue of $486-496 million vs. consensus of $307.05 million. It raised its 2008 revenue estimate from $1.08-1.18 billion to $1.65-1.75 billion. This is again far higher than analysts estimates of $1.15 billion.
LDK has been a hot stock in a hot sector. Its shares have enjoyed a wild ride in 2007 as concerns over soaring oil prices and global warming have boosted the sector, culminating in LDK recording a 52-week high of $76.75 in late September of '07. Since then, new concerns over Spanish government cutting subsidies sent solar stocks lower.
The effect of these lower subsidies on the sector and LDK remains to be seen as perhaps they could be offset by orders from other European countries. LDK, though, is also trying to control its raw material costs by building polysilicon plants, the progress of which has been "tremendous" according to the company.
Last updated: February 13, 2012: 02:11 AM
Hot Stocks
DailyFinance Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
Benzinga Headlines
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
TheFlyOnTheWall.com Headlines
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger

